Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency. [electronic resource]
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jun 2015
- 1657-62 p. digital
Publication Type: Journal Article
1433-7339
10.1007/s00520-014-2521-8 doi
Aged Aged, 80 and over Antibodies, Monoclonal, Humanized--adverse effects Bone Density Conservation Agents--adverse effects Bone Neoplasms--secondary Denosumab Diphosphonates--therapeutic use Female Humans Hypocalcemia--chemically induced Hypophosphatemia--chemically induced Male Middle Aged Neoplasms, Second Primary--therapy Renal Insufficiency--complications Retrospective Studies